Cargando…

Vasopressors and Inotropes in Acute Myocardial Infarction Related Cardiogenic Shock: A Systematic Review and Meta-Analysis

Vasopressors and inotropes are routinely used in acute myocardial infarction (AMI) related cardiogenic shock (CS) to improve hemodynamics. We aimed to investigate the effect of routinely used vasopressor and inotropes on mortality in AMI related CS. A systematic search of MEDLINE, EMBASE and CENTRAL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karami, Mina, Hemradj, Veemal V., Ouweneel, Dagmar M., den Uil, Corstiaan A., Limpens, Jacqueline, Otterspoor, Luuk C., Vlaar, Alexander P., Lagrand, Wim K., Henriques, José P. S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408805/ https://www.ncbi.nlm.nih.gov/pubmed/32629772 http://dx.doi.org/10.3390/jcm9072051

Ejemplares similares

Vasopressors and inotropes in cardiogenic shock: is there room for “adrenaline resuscitation”?
por: Morici, Nuccia, et al.
Publicado: (2016)

State of Shock: Contemporary Vasopressor and Inotrope Use in Cardiogenic Shock
por: Bloom, Jason E., et al.
Publicado: (2023)

The Usage of Concomitant Beta-Blockers with Vasopressors and Inotropes in Cardiogenic Shock
por: Ryu, Rachel, et al.
Publicado: (2022)

Pre-PCI versus immediate post-PCI Impella initiation in acute myocardial infarction complicated by cardiogenic shock
por: Hemradj, Veemal V., et al.
Publicado: (2020)

Real-life use of vasopressors and inotropes in cardiogenic shock—observation is necessarily ‘theory-laden’
por: Ray, Samiran, et al.
Publicado: (2016)

Outcome and Predictors for Mortality in Patients with Cardiogenic Shock: A Dutch Nationwide Registry-Based Study of 75,407 Patients with Acute Coronary Syndrome Treated by PCI
por: Karami, Mina, et al.
Publicado: (2021)

Vasopressor stays vasopressor and inotrope stays inotrope!
por: Luckner, Günter, et al.
Publicado: (2008)

Long-term 5-year outcome of the randomized IMPRESS in severe shock trial: percutaneous mechanical circulatory support vs. intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction
por: Karami, Mina, et al.
Publicado: (2021)

Extracorporeal life support during cardiac arrest and cardiogenic shock: a systematic review and meta-analysis
por: Ouweneel, Dagmar M., et al.
Publicado: (2016)

Current real-life use of vasopressors and inotropes in cardiogenic shock - adrenaline use is associated with excess organ injury and mortality
por: Tarvasmäki, Tuukka, et al.
Publicado: (2016)

Vasopressors and Inotropes in the Treatment of Human Septic Shock: Effect on Innate Immunity?
por: Hartemink, Koen J., et al.
Publicado: (2011)

Predictors of In-hospital Mortality in Cardiogenic Shock Patients on Vasoactive or Inotropic Support
por: Nandkeolyar, Shuktika, et al.
Publicado: (2021)

Inotropic support in cardiogenic shock: who leads the battle, milrinone or dobutamine?
por: Lozada Martinez, Ivan David, et al.
Publicado: (2022)

Dopamine versus norepinephrine as the first-line vasopressor in the treatment of cardiogenic shock
por: Na, Soo Jin, et al.
Publicado: (2022)

Conventional Hemodynamic Resuscitation May Fail to Optimize Tissue Perfusion: An Observational Study on the Effects of Dobutamine, Enoximone, and Norepinephrine in Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock
por: den Uil, Corstiaan A., et al.
Publicado: (2014)

Postpartum cardiogenic shock due to coronary artery spasm after methylergometrine and sulprostone administration
por: Zomer, Pim M. L., et al.
Publicado: (2023)

Real-life use of left ventricular circulatory support with Impella in cardiogenic shock after acute myocardial infarction: 12 years AMC experience
por: Ouweneel, Dagmar M, et al.
Publicado: (2018)

Characteristics, Treatment Strategies and Outcome in Cardiogenic Shock Complicating Acute Myocardial Infarction: A Contemporary Dutch Cohort
por: Peters, Elma J., et al.
Publicado: (2023)

Cerebral Effects of Commonly Used Vasopressor-Inotropes: A Study in Newborn Piglets
por: Hahn, Gitte H., et al.
Publicado: (2013)

Mechanical Support in Early Cardiogenic Shock: What Is the Role of Intra-aortic Balloon Counterpulsation?
por: Kimman, Jesse R., et al.
Publicado: (2020)

Choice of vasopressor in septic shock: does it matter?
por: Patel, Gourang P, et al.
Publicado: (2007)

Current use of inotropes in circulatory shock
por: Scheeren, Thomas W. L., et al.
Publicado: (2021)

VASOPRESSOR-RESISTANT HYPOTENSION, COMBINATION VASOPRESSOR THERAPY, AND SHOCK PHENOTYPES IN CRITICALLY ILL ADULTS WITH VASODILATORY SHOCK
por: Priyanka, Priyanka, et al.
Publicado: (2022)

Impact of baseline beta-blocker use on inotrope response and clinical outcomes in cardiogenic shock: a subgroup analysis of the DOREMI trial
por: Di Santo, Pietro, et al.
Publicado: (2021)

“Assessing the hemodynamic impact of various inotropes combination in patients with cardiogenic shock with Non-ST elevation myocardial infarction –the ANAPHOR study”
por: Sharma, Kamal, et al.
Publicado: (2021)

Threshold of Inotropic Score and Vasoactive–Inotropic Score for Predicting Mortality in Pediatric Septic Shock
por: Kallekkattu, Dipu, et al.
Publicado: (2021)

Current use of vasopressors in septic shock
por: Scheeren, Thomas W. L., et al.
Publicado: (2019)

Vasopressors in Septic Shock: The Quest for Refinement
por: Pichamuthu, Kishore
Publicado: (2022)

Inotrope Use and Intensive Care Unit Mortality in Patients With Cardiogenic Shock: An Analysis of a Large Electronic Intensive Care Unit Database
por: Gao, Fei, et al.
Publicado: (2021)

Influence of vasopressor agent in pediatric septic shock mortality
por: Mangia, CMF, et al.
Publicado: (2011)

Vasopressor requirement during targeted temperature management for out-of-hospital cardiac arrest caused by acute myocardial infarction without cardiogenic shock
por: Song, Gyuho, et al.
Publicado: (2016)

Fluids or vasopressors for the initial resuscitation of septic shock
por: Macdonald, Stephen, et al.
Publicado: (2022)

Phenotyping cardiogenic shock that showed different clinical outcomes and responses to vasopressor use: a latent profile analysis from MIMIC-IV database
por: Yu, Yue, et al.
Publicado: (2023)

Cardiogenic shock /
Publicado: (2002)

Cardiogenic Shock
por: Vahdatpour, Cyrus, et al.
Publicado: (2019)

Does vasopressor therapy have an indication in hemorrhagic shock?
por: Beloncle, François, et al.
Publicado: (2013)

Therapeutic Strategies for High-Dose Vasopressor-Dependent Shock
por: Bassi, Estevão, et al.
Publicado: (2013)

Vasopressors: Do they have any role in hemorrhagic shock?
por: Gupta, Babita, et al.
Publicado: (2017)

Vasopressors in septic shock: which, when, and how much?
por: Shi, Rui, et al.
Publicado: (2020)

Adjunctive vasopressors in distributive shock: How soon is early?
por: Garcia, Bruno, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qjkjs4beaseujr9qdshqq017io